

![]() |
BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients |
|
Authors | ![]() | |
Published in | Breast cancer research and treatment. 2019, vol. 174, no. 3, p. 775-783 | |
Abstract | BRCA1 and BRCA2 proteins are central to DNA repair process through homologous recombination. We hypothesize that BRCA1/BRCA2 mutation carriers may exhibit increased hematological toxicity when receiving genotoxic chemotherapy. | |
Identifiers | PMID: 30635808 | |
Full text | ||
Structures | ||
Citation (ISO format) | FRIEDLAENDER, Alex et al. BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients. In: Breast Cancer Research and Treatment, 2019, vol. 174, n° 3, p. 775-783. doi: 10.1007/s10549-018-05127-2 https://archive-ouverte.unige.ch/unige:120074 |